A Pharmacodynamic Comparison of Prasugrel vs. Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Thrombosis
- Focus Pharmacodynamics
- Acronyms OPTIMUS-4
- 24 Aug 2016 Primary endpoint (Platelet reactivity) has been met according to the results published in the Circulation.
- 24 Aug 2016 Results published in the Circulation
- 01 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.